Myorelax 100 mg/ml Oplossing voor infusie
Myorelax 100 mg/ml Oplossing voor infusie
Authorised
- Guaifenesin
Product identification
Medicine name:
Myorelax 100 mg/ml Oplossing voor infusie
Myorelax 100 mg/ml Solution pour perfusion
Myorelax 100 mg/ml Injektionslösung
Active substance:
- Guaifenesin
Target species:
-
Horse (pony)
-
Horse
Route of administration:
-
Intravenous use
Product details
Active substance and strength:
-
Guaifenesin100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for infusion
Withdrawal period by route of administration:
-
Intravenous use
-
Horse (pony)
-
Milkno withdrawal periodDo not use with animals aimed for human consumption
-
Meat and offalno withdrawal periodDo not use with animals aimed for human consumption
-
-
Horse
-
Milkno withdrawal periodDo not use with animals aimed for human consumption
-
Meat and offalno withdrawal periodDo not use with animals aimed for human consumption
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM03BX90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Myorelax 1 Vial with 500 ml Solution for infusion
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Veterinary Products
Marketing authorisation date:
Manufacturing sites for batch release:
- Eurovet Animal Health B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V116261
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
